论文部分内容阅读
本文采用标准试验餐加固体小钡条作胃排空检查以观察糖尿病人胃排空状态及糖尿病伴胃轻瘫病人普瑞博思治疗效果。结果显示：（１）糖尿病人胃排空障碍发生率３８８９％，与正常对照组相比有非常显著差异（Ｐ＜０．００５，ｘ２值为１０．９３）；（２）糖尿病伴胃轻瘫组与糖尿病无胃轻瘫组相比，具有病程长、血糖水平高的特点；（３）普瑞博思１０ｍｇ，３次／日治疗两周后，糖尿病伴胃轻瘫病人的胃排空时间明显缩短，胃轻瘫症状评分明显下降（Ｐ值分别为＜０．０１和＜０．００１）。结论：胃轻瘫是糖尿病常见的并发症之一，多见于病程长、血糖水平高的病人，普瑞博思是治疗糖尿病性胃轻瘫的有效药物。
In this paper, a standard test meal plus solid barium barium for gastric emptying in order to observe the status of diabetic patients with gastric emptying and diabetic patients with gastroparesis Puriper effect. The results showed that: (1) The incidence of gastric emptying in diabetic patients was 3889%, which was significantly different from the normal control group (P <0.005, x2 = 10.93); (2) Compared with the diabetic group without gastroparesis, the paresis group had longer duration and high blood sugar level. (3) After two weeks of pregabalin 10 mg and 3 times / day, the gastric emptying in diabetic patients with gastroparesis The time was significantly shortened and the symptom scores of gastroparesis decreased significantly (P <0.01 and <0.001, respectively). Conclusion: Gastroparesis is one of the common complications of diabetes. It is more common in patients with long duration and high blood sugar level. Pregabalus is an effective drug in the treatment of diabetic gastroparesis.